The use of lipid-based formulations to increase the oral bioavailability of panax notoginseng saponins following a single oral gavage to rats

Drug Development and Industrial Pharmacy

Volumn 34, Issue 1, 2008, Pages 65-72

  Xiong, Jing ^a   Guo, Jianxin ^a   Huang, Luosheng ^a   Meng, Boyu ^a   Ping, Qineng ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Ginsenoside Rb1; Ginsenoside Rg1; Oil solution; Oral relative bioavailability; Panax notoginseng saponins; PNS phospholipid complex

Indexed keywords

ACYLGLYCEROL; ESTER; GINSENOSIDE RB 1; GINSENOSIDE RG 1; OCTANOIN; PANAX NOTOGINSENG EXTRACT; PHOSPHOLIPID; SAPONIN;

AQUEOUS SOLUTION; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; FEEDING; HYDROPHILICITY; HYDROPHOBICITY; MALE; NONHUMAN; PLASMA CONCENTRATION-TIME CURVE; RAT;

ANIMALS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GINSENOSIDES; PANAX NOTOGINSENG; PHOSPHOLIPIDS; RATS; SOLUBILITY;

EID: 38549110471     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040701508292     Document Type: Article

References (32)

1. Aungst, B. J., Saitoh, H., Burchman, D. L., Huang, S.-M., Mousa, S. A., & Hussain, M. A. (1996). Enhancement of the intestinal absorption of peptides and nonpeptides. J. Control. Release, 41, 19-31.
2. Benishin, C. G., Lee, R., Wang, L. C., & Liu, H. J. (1991). Effects of ginsenoside Rb1 on central cholinergic metabolism. Pharmacology, 42, 223-229.
3. Beskid, G., Unowsky, J., Behl, C. R., Siebelist, J., Tossounian, J. L., & McGarry, C. M., et al. (1988). Enteral, oral, and rectal absorption of ceftriaxone using glyceride enhancers. Chemotherapy, 34, 77-84.
4. Buhlmayer, P., Caselli, A., Fuhrer, W., Goschkler, R., Rasetti, V., & Rueger, H., et al. (1988). Synthesis and biological activity of some transition-state inhibitors of human renin. J. Med. Chem., 31, 1839-1846.
5. Caliph, S. M., Charman, W. N., & Porter, C. J. H. (2000). Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats. J. Pharm. Sci., 89, 1073-1084.
6. Constanitinides, P. P., Scalart, J. P., Lancaster, C., Marcello, J., Marks, G., & Ellens, H., et al. (1994). Formulation and intestinal absorption enhancement evaluation of water-in-oil microemulsions incorporating medium-chain glycerides. Pharm. Res., 11, 1385-1390.
7. Cournarie, F., Auchere, D., Chevenne, D., Lacour, B., Seiller, M., & Vauthir, C. (2002). Absorption and efficiency of insulin after oral administration of insulin-loaded nanocapsules in diabetic rats. Int. J. Pharm., 242, 325-328.
8. Fukui, E., Kurohara, H., Kageyu, A., Kurosaki, Y., Nakayama, T., & Kimura, T. (1989). Enhancing effect of medium-chain triglycerides on intestinal absorption of d-alpha-tocopherol acetate from lecithindispersed solutions in the rat. J. Pharmacobio-dyn., 12, 80-86.
9. Han, M., & Fang, X.-L. (2006). Difference in oral absorption of ginsenoside Rg1 between in vitro and in vivo models. Acta Pharmacol. Sin., 27, 499-505.
10. Han, M., Sha, X., Wu, Y., & Fang, X. (2006). Oral absorption of ginsenoside Rb1 using in vitro and in vivo models. Planta Med., 72, 398-404.
11. Hasegawa, H., Sung, J. H., Matsumiya, S., & Uchiyama, M. (1996). Main ginseng saponin metabolites formed by intestinal bacteria. Planta Med., 62, 453-457.
12. Kanaoks, M., Akao, T., & Kobashi, K. (1994). Metabolism of ginseng saponins, ginsenoside, by human intestinal flora. J. Traditional Medicine, 11, 241-246.
13. Kiyasu, J. Y., Bloom, B., & Chaikoff, I. L. (1952). The portal transport of absorbed fatty acids. J. Biol. Chem., 199, 415-419.
14. Kleinert, H. D., Rosenberg, S. H., Baker, W. R., Stein, H. H., Klinghofer, V., & Barlow, J., et al. (1992). Discovery of a peptide-based renin inhibitor with oral bioavailability and efficacy. Science, 257, 1940-1943.
15. Lee, V. H. L. (1990). Protease inhibitors and penetration enhancers as approaches to modify peptide absorption. J. Control. Release, 13, 213-223
16. Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev., 46, 3-26.
17. Lohikangas, L., Wilen, M., Einarsson, M., & Artursson, P. (1994). Effects of a new lipid-based drug delivery system on the absorption of low molecular weight heparin (Fragmin) through mnnolayers of human intestinal epithelial Caco-2 cells and after rectal administration to rabbits. Eur. J. Pharm. Sci., 1, 297-305.
18. Muramatsu, K., Maitani, Y., & Nagai, T. (1996). Dipalmitoylphosphatidylcholine liposomes with soybean-derived sterols and cholesterol as a carrier for the oral administration of insulin in rats. Biol. Pharm. Bull., 19, 1055-1058.
19. Nankervis, R., Davis, S. S., Day, N. H., & Shaw, P. N. (1996). Intestinal lymphatic transport of three retinoids in the rat after oral administration: effect of lipophilicity and lipid vehicle. Int. J. Pharm., 130, 57-64.
20. New, R. R. C., & Kirby, C. J. (1999). Solubilisation aids. U.S. Patent 5968549.
21. Odani, T., Tanizawa, H., & Takino, Y. (1983). Studies on the absorption, distribution, excretion and metabolism of ginseng saponins. II. 1) The absorption, distribution and excretion of ginsenoside Rg1 in the rat. Chem. Pharm. Bull., 31, 292-298.
22. Porter, C. J. H., & Charman, W. N. (1997). Uptake of drugs into the intestinal lymphatics after oral administration. Adv. Drug Deliv. Rev., 25, 71-89.
23. Sasaki, K., Yonebayashi, S., Yoshida, M., Shimizu, K., Aotsuka, T., & Takayama, K. (2003). Improvement in the bioavailability of poorly absorbed glycyrrhizin via various non-vascular administration routes in rats. Int. J. Pharm., 265, 95-102.
24. Shen, Y. J. (2000). Pharmacology of traditional Chinese medicine. Beijing, China: Renmin Weisheng Press.
25. Swenson, E. S., & Curatolo, W. J. (1992). Means to enhance penetration intestinal permeability enhancement for proteins, peptides and other polar drugs: mechanisms and potential toxicity. Adv. Drug Deliv. Rev., 8, 39-92.
26. Takino, Y. (1994). Studies on the pharmacodynamics of ginsenoside-Rg1, -Rb1 and -Rb2 in rats. Yakugaku Zasshi, 114, 550-564.
27. Takino, Y., Odani, T., Tanizawa, H., & Hayashi, T. (1982). Studies on the absorption, distribution, excretion and metabolism of ginseng saponins. I. 1). Quantitative analysis of ginsenoside Rg1 in rats. Chem. Pharm. Bull., 30, 2196-2201.
28. Ueda, I., Shimojo, F., & Kozatani, J. (1983). Effect of ethyl cellulose in a medium-chain triglyceride on the bioavailability of ceftizoxime. J. Pharm. Sci., 72, 454-458.
29. Unowsky, J., Behl, C. R., Beskid, G., Sattler, J., Halpern, J., & Cleeland, R. (1988). Effect of medium chain glycerides on enteral and rectal absorption of beta-1actam and aminoglycoside antibiotics. Chemotherapy, 34, 272-276.
30. Yanyu, X., Yunmei, S., Zhipeng, C., & Qineng, P. (2006). The preparation of silybin-phospholipid complex and the study on its pharmacokinetics in rats. Int. J. Pharm., 307, 77-82.
31. Yeh, P.-Y., Berenson, M. M., & Samowitz, W. S., Kova, P. K., & Kopecek, J. I., (1995). Site-specific drug delivery and penetration enhancement in the gastrointestinal tract. J. Control. Release, 36, 109-124.
32. Zheng, G. Z. (1994). Biology and application of Panax notoginseng. Beijing, China: Science Press.